Intuitive Surgical (ISRG) trades pre-market at $499.53, slightly down, as investors weigh its leading position in robotic-assisted surgery against its premium valuation. Despite trading below its 50 and 200-day averages, the company maintains strong fundamentals and R&D investment in AI-driven healthcare. Meyka AI gives ISRG a “BUY” rating with a 12-month price target of $604.32, seeing significant upside potential amidst some short-term volatility and valuation concerns.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
ISRG Intuitive Surgical (NASDAQ) pre-market $499.53 on 20 Feb 2026: AI-enabled devices guide outlook
Intuitive Surgical (ISRG) trades pre-market at $499.53, slightly down, as investors weigh its leading position in robotic-assisted surgery against its premium valuation. Despite trading below its 50 and 200-day averages, the company maintains strong fundamentals and R&D investment in AI-driven healthcare. Meyka AI gives ISRG a “BUY” rating with a 12-month price target of $604.32, seeing significant upside potential amidst some short-term volatility and valuation concerns.